DNA Pain is a genetic test designed to enhance the successful and sustained management of chronic pain.
By analysing the genes involved in biological pathways known to affect the risk of chronic pain; the report will identify the key areas that are contributing to chronic pain, and more importantly, how to alleviate these symptoms through personalised diet, supplement, exercise, and lifestyle interventions.
DNA Pain will benefit individuals suffering from a chronic pain condition, including fibromyalgia or musculoskeletal pain, who would like to take a personalised and holistic approach to pain management. Individuals suffering from comorbid conditions associated with chronic pain, such as anxiety or depression, will also benefit from the personalised recommendations in this test.
If you are using pharmaceutical medications as part of your pain treatment, the Medcheck test should be considered alongside DNA Pain to provide insight into the responsiveness and possible side effects related to pain management medication, including opioids.